# Pharmacokinetic Issues of Moxifloxacin Plus Rifapentine

> **NCT00460759** · PHASE1 · TERMINATED · sponsor: **Johns Hopkins University** · enrollment: 15 (actual)

## Conditions studied

- Mycobacterium Tuberculosis

## Interventions

- **DRUG:** Moxifloxacin
- **DRUG:** Rifapentine

## Key facts

- **NCT ID:** NCT00460759
- **Lead sponsor:** Johns Hopkins University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-06
- **Primary completion:** 2008-08-24
- **Final completion:** 2008-08-24
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2017-12-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00460759

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00460759, "Pharmacokinetic Issues of Moxifloxacin Plus Rifapentine". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00460759. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*